Literature DB >> 15288831

Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth.

Tânia Mara Pimenta Amaral1, Addah Regina Da Silva Freire, André Lopes Carvalho, Clóvis Antônio Lopes Pinto, Luiz Paulo Kowalski.   

Abstract

The incidence of occult neck metastasis in early stage tumours of the tongue and floor of the mouth varies from 20% to 30%, and the survival rates in 5 years from 73% to 97%. This study analyzes the rates of occult metastasis and prognostic factors for clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. The records of patients with squamous cell carcinoma of the tongue and floor of the mouth, without prior treatment and treated by surgery between 1965 and 1998 were reviewed. All cases were re-staged and the surgical specimens were reviewed. This study included 193 patients, 145 men (75.1%), with ages ranging from 29 to 89 years old (mean, 60 years). The tumour site was the tongue in 132 cases (68.4%), the floor of the mouth in 45 (23.3%) and both in 16 (8.3%). With regard to stage, 85 cases were at clinical stage I (44.0%) and 108, clinical stage II (56.0%). One hundred and seventeen patients (60.6%) were submitted to a neck dissection and 27 (23.1%) had metastasic lymph nodes (pN+). The only factor associated with the presence of occult metastasis for all patients was the presence of muscular infiltration (p = 0.020); for tongue tumours the presence of vascular embolization (p = 0.043) and the presence of desmoplastic reaction (p = 0.050); for floor of the mouth tumours and T2 tumors, the histological grade (p = 0.025 and p = 0.035, respectively). Disease-free survival in 5 years was 66.4% and overall survival in 5 years 68.5%. The only factor associated with disease-free survival was the presence of muscular infiltration (p = 0.019) and with overall survival were gender (p = 0.002) and clinical stage (p = 0.031). Tumours of the tongue and floor of the mouth in the initial stages, which had muscular infiltration showed a higher probability of occult metastasis and lower disease-free survival; T2 tumours showed a worse survival as did patients of the male gender.

Entities:  

Mesh:

Year:  2004        PMID: 15288831     DOI: 10.1016/j.oraloncology.2003.10.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  40 in total

1.  Eosinophils may predict occult lymph node metastasis in early oral cancer.

Authors:  D T Oliveira; T P Biassi; S E S Faustino; A L Carvalho; G Landman; L P Kowalski
Journal:  Clin Oral Investig       Date:  2011-12-14       Impact factor: 3.573

Review 2.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

3.  Cervical Metastases Behavior of T1-2 Squamous Cell Carcinoma of the Tongue.

Authors:  K Sagheb; V Kumar; R Rahimi-Nedjat; M Dollhausen; T Ziebart; B Al-Nawas; C Walter
Journal:  J Maxillofac Oral Surg       Date:  2016-06-28

4.  Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue.

Authors:  Murat Doğan; Sedat Çağlı; İmdat Yüce; Ali Bayram; Mehmet Akif Somdaş; Duran Karataş; Mehmet Celalettin Cihan; Fatih Yüksel; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

5.  Affect on survival per increase in each millimeter of tumor depth in tongue cancer.

Authors:  Sandhya Gokavarapu; Murtaza Ahmed; Nagendra Parvataneni; K V V N Raju; Ravi Chander; L M Chandrasekhara Rao S
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-04

6.  Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.

Authors:  Serdar Karahatay; Kesha Thomas; Serap Koybasi; Can E Senkal; Saeed Elojeimy; Xiang Liu; Jacek Bielawski; Terry A Day; M Boyd Gillespie; Debajyoti Sinha; James S Norris; Yusuf A Hannun; Besim Ogretmen
Journal:  Cancer Lett       Date:  2007-07-09       Impact factor: 8.679

7.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  L W T Alkureishi; Z Burak; J A Alvarez; J Ballinger; A Bilde; A J Britten; L Calabrese; C Chiesa; A Chiti; R de Bree; H W Gray; K Hunter; A F Kovacs; M Lassmann; C R Leemans; G Mamelle; M McGurk; J Mortensen; T Poli; T Shoaib; P Sloan; J A Sorensen; S J Stoeckli; J B Thomsen; G Trifiro; J Werner; G L Ross
Journal:  Ann Surg Oncol       Date:  2009-11       Impact factor: 5.344

8.  Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years.

Authors:  Astrid L D Kruse; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2009-07-20

9.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

10.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  Lee W T Alkureishi; Zeynep Burak; Julio A Alvarez; James Ballinger; Anders Bilde; Alan J Britten; Luca Calabrese; Carlo Chiesa; Arturo Chiti; Remco de Bree; Harry W Gray; Keith Hunter; Adorjan F Kovacs; Michael Lassmann; C Rene Leemans; Gerard Mamelle; Mark McGurk; Jann Mortensen; Tito Poli; Taimur Shoaib; Philip Sloan; Jens A Sorensen; Sandro J Stoeckli; Jorn B Thomsen; Giusepe Trifiro; Jochen Werner; Gary L Ross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.